Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Mitochondria as targets for cancer chemotherapy

Gogvadze, Vladimir, Orrenius, Sten, Zhivotovsky, Boris · 2009 · Seminars in Cancer Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2008.11.007

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 96

  1. Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  2. Simonnet, 2002, Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma, Carcinogenesis, 23, 759, 10.1093/carcin/23.5.759 · DOI · Paper page
  3. Nakashima, 1984, Contributions of glycolysis and oxidative phosphorylation to adenosine 5’-triphosphate production in AS-30D hepatoma cells, Cancer Res, 44, 5702
  4. Weinhouse, 1976, The Warburg hypothesis fifty years later, Z Krebsforsch Klin Onkol Cancer Res Clin Oncol, 87, 115, 10.1007/BF00284370 · DOI · Paper page
  5. Hammond, 2005, The role of p53 in hypoxia-induced apoptosis, Biochem Biophys Res Commun, 331, 718, 10.1016/j.bbrc.2005.03.154 · DOI · Paper page
  6. Moll, 1998, Schramm LM. p53--an acrobat in tumorigenesis, Crit Rev Oral Biol Med, 9, 23, 10.1177/10454411980090010101 · DOI
  7. Semenza, 1996, Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1, J Biol Chem, 271, 32529, 10.1074/jbc.271.51.32529 · DOI · Paper page
  8. Wang, 1976, Aerobic glycolysis during lymphocyte proliferation, Nature, 261, 702, 10.1038/261702a0 · DOI · Paper page
  9. Ibsen, 1961, The Crabtree effect: a review, Cancer Res, 21, 829
  10. Guppy, 1993, The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes, Eur J Biochem, 212, 95, 10.1111/j.1432-1033.1993.tb17637.x · DOI · Paper page
  11. Wojtczak, 1999, Effect of glucose and deoxyglucose on the redistribution of calcium in ehrlich ascites tumour and Zajdela hepatoma cells and its consequences for mitochondrial energetics. Further arguments for the role of Ca(2+) in the mechanism of the crabtree effect, Eur J Biochem, 263, 495, 10.1046/j.1432-1327.1999.00522.x · DOI
  12. Lopez-Rios, 2007, Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas, Cancer Res, 67, 9013, 10.1158/0008-5472.CAN-07-1678 · DOI · Paper page
  13. Pelicano, 2004, ROS stress in cancer cells and therapeutic implications, Drug Resist Updat, 7, 97, 10.1016/j.drup.2004.01.004 · DOI · Paper page
  14. Storz, 2005, Reactive oxygen species in tumor progression, Front Biosci, 10, 1881, 10.2741/1667 · DOI · Paper page
  15. Polyak, 1998, Somatic mutations of the mitochondrial genome in human colorectal tumours, Nat Genet, 20, 291, 10.1038/3108 · DOI · Paper page
  16. Brand, 2004, Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins, Free Radic Biol Med, 37, 755, 10.1016/j.freeradbiomed.2004.05.034 · DOI · Paper page
  17. Derdak, 2008, The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells, Cancer Res, 68, 2813, 10.1158/0008-5472.CAN-08-0053 · DOI · Paper page
  18. Fang, 2007, Tumor-targeted induction of oxystress for cancer therapy, J Drug Target, 15, 475, 10.1080/10611860701498286 · DOI · Paper page
  19. Kong, 1998, Antioxidant inhibitors for cancer therapy, Med Hypotheses, 51, 405, 10.1016/S0306-9877(98)90036-6 · DOI
  20. Huang, 2000, Superoxide dismutase as a target for the selective killing of cancer cells, Nature, 407, 390, 10.1038/35030140 · DOI · Paper page
  21. Engel, 2006, Oxidative stress and apoptosis: a new treatment paradigm in cancer, Front Biosci, 11, 300, 10.2741/1798 · DOI · Paper page
  22. Kerr, 1972, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer, 26, 239, 10.1038/bjc.1972.33 · DOI · Paper page
  23. Orrenius, 2003, Regulation of cell death: the calcium-apoptosis link, Nat Rev Mol Cell Biol, 4, 552, 10.1038/nrm1150 · DOI · Paper page
  24. Proskuryakov, 2003, Necrosis: a specific form of programmed cell death?, Exp Cell Res, 283, 1, 10.1016/S0014-4827(02)00027-7 · DOI · Paper page
  25. Kitanaka, 1999, Caspase-independent programmed cell death with necrotic morphology, Cell Death Differ, 6, 508, 10.1038/sj.cdd.4400526 · DOI · Paper page
  26. Morgan, 2008, TNFalpha and reactive oxygen species in necrotic cell death, Cell Res, 18, 343, 10.1038/cr.2008.31 · DOI · Paper page
  27. Boujrad, 2007, AIF-mediated programmed necrosis: a highly regulated way to die, Cell Cycle, 6, 2612, 10.4161/cc.6.21.4842 · DOI · Paper page
  28. Gozuacik, 2004, Autophagy as a cell death and tumor suppressor mechanism, Oncogene, 23, 2891, 10.1038/sj.onc.1207521 · DOI · Paper page
  29. Moretti, 2007, Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy, Drug Resist Updat, 10, 135, 10.1016/j.drup.2007.05.001 · DOI
  30. Hippert, 2006, Autophagy in cancer: good, bad, or both?, Cancer Res, 66, 9349, 10.1158/0008-5472.CAN-06-1597 · DOI · Paper page
  31. Karantza-Wadsworth, 2007, Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis, Genes Dev, 21, 1621, 10.1101/gad.1565707 · DOI · Paper page
  32. Kim, 2008, Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer, Autophagy, 4, 659, 10.4161/auto.6058 · DOI · Paper page
  33. Bras, 2005, Programmed cell death via mitochondria: different modes of dying, Biochemistry (Mosc), 70, 231, 10.1007/s10541-005-0105-4 · DOI · Paper page
  34. Tsujimoto, 1987, Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma, Oncogene, 2, 3
  35. Tsujimoto, 2000, Bcl-2 family: life-or-death switch, FEBS Lett, 466, 6, 10.1016/S0014-5793(99)01761-5 · DOI · Paper page
  36. Hockenbery, 1990, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334, 10.1038/348334a0 · DOI · Paper page
  37. Hennet, 1993, Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity, Cancer Res, 53, 1456
  38. Festjens, 2004, Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death, Acta Haematol, 111, 7, 10.1159/000074483 · DOI
  39. Cory, 2003, The Bcl-2 family: roles in cell survival and oncogenesis, Oncogene, 22, 8590, 10.1038/sj.onc.1207102 · DOI · Paper page
  40. Wei, 2001, Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death, Science, 292, 727, 10.1126/science.1059108 · DOI · Paper page
  41. Abel, 2005, Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology, Eur J Cancer, 41, 635, 10.1016/j.ejca.2004.12.021 · doi:10.1016/j.ejca.2004.12.021
  42. Hunter, 1979, The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms, Arch Biochem Biophys, 195, 453, 10.1016/0003-9861(79)90371-0 · DOI · Paper page
  43. Crompton, 2000, Mitochondrial intermembrane junctional complexes and their role in cell death, J Physiol, 529, 11, 10.1111/j.1469-7793.2000.00011.x · DOI · Paper page
  44. Leung, 2008, Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore, Biochim Biophys Acta, 1777, 946, 10.1016/j.bbabio.2008.03.009 · DOI · Paper page
  45. Evtodienko, 1999, The Ca2+ threshold for the mitochondrial permeability transition and the content of proteins related to Bcl-2 in rat liver and Zajdela hepatoma mitochondria, Mol Cell Biochem, 194, 251, 10.1023/A:1006913526643 · DOI
  46. Kinnally, 2007, A tale of two mitochondrial channels, MAC and PTP, in apoptosis, Apoptosis, 12, 857, 10.1007/s10495-007-0722-z · DOI · Paper page
  47. Pavlov, 2001, A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast, J Cell Biol, 155, 725, 10.1083/jcb.200107057 · DOI · Paper page
  48. Ott, 2002, Cytochrome c release from mitochondria proceeds by a two-step process, Proc Natl Acad Sci U S A, 99, 1259, 10.1073/pnas.241655498 · DOI · Paper page
  49. Orrenius, 2007, Mitochondrial oxidative stress: implications for cell death, Annu Rev Pharmacol Toxicol, 47, 143, 10.1146/annurev.pharmtox.47.120505.105122 · DOI · Paper page
  50. Scatena, 2008, Glycolytic enzyme inhibitors in cancer treatment, Expert Opin Investig Drugs, 17, 1533, 10.1517/13543784.17.10.1533 · DOI · Paper page
  51. Halicka, 1995, 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor, Cancer Res, 55, 444
  52. Geschwind, 2002, Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production, Cancer Res, 62, 3909
  53. Xu, 2005, Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia, Cancer Res, 65, 613, 10.1158/0008-5472.613.65.2 · DOI · Paper page
  54. Cao, 2007, Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia, Cancer Chemother Pharmacol, 59, 495, 10.1007/s00280-006-0291-9 · DOI · Paper page
  55. Adams, 2007, The Bcl-2 apoptotic switch in cancer development and therapy, Oncogene, 26, 1324, 10.1038/sj.onc.1210220 · DOI · Paper page
  56. Oltersdorf, 2005, An inhibitor of Bcl-2 family proteins induces regression of solid tumours, Nature, 435, 677, 10.1038/nature03579 · DOI · Paper page
  57. Huang, 2008, BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells, Cancer Res, 68, 2944, 10.1158/0008-5472.CAN-07-2508 · DOI
  58. Kang, 2007, Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo, Blood, 110, 2057, 10.1182/blood-2007-03-080325 · DOI
  59. Kuroda, 2008, ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms, Br J Haematol, 140, 181, 10.1111/j.1365-2141.2007.06899.x · DOI
  60. Vogler, 2008, A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells, Cell Death Differ, 15, 820, 10.1038/cdd.2008.25 · DOI
  61. Gogvadze, 2001, Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax, J Biol Chem, 276, 19066, 10.1074/jbc.M100614200 · DOI · Paper page
  62. Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ. 2008 Sep 19. [Epub ahead of print] PMID: 18806758. · DOI · Paper page
  63. Ponassi, 2008, A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity, Cell Cycle, 7, 3211, 10.4161/cc.7.20.6830 · doi:10.4161/cc.7.20.6830
  64. Lin, 2004, Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3, Cell, 116, 527, 10.1016/S0092-8674(04)00162-X · DOI · Paper page
  65. Kolluri, 2008, A short Nur77-derived peptide converts Bcl-2 from a protector to a killer, Cancer Cell, 14, 285, 10.1016/j.ccr.2008.09.002 · DOI · Paper page
  66. Wang, 2000, Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells, Proc Natl Acad Sci U S A, 97, 7124, 10.1073/pnas.97.13.7124 · DOI · Paper page
  67. Tzung, 2001, Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3, Nat Cell Biol, 3, 183, 10.1038/35055095 · DOI · Paper page
  68. Campas, 2006, Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells, Exp Hematol, 34, 1663, 10.1016/j.exphem.2006.07.008 · DOI
  69. Konopleva, 2008, Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax), Cancer Res, 68, 3413, 10.1158/0008-5472.CAN-07-1919 · DOI · Paper page
  70. Larochette, 1999, Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore, Exp Cell Res, 249, 413, 10.1006/excr.1999.4519 · DOI · Paper page
  71. Nutt, 2005, Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis, Cancer Biol Ther, 4, 459, 10.4161/cbt.4.4.1652 · DOI
  72. Robertson, 2000, Distinct pathways for stimulation of cytochrome c release by etoposide, J Biol Chem, 275, 32438, 10.1074/jbc.C000518200 · DOI
  73. Pastorino, 2008, Regulation of hexokinase binding to VDAC, J Bioenerg Biomembr, 40, 171, 10.1007/s10863-008-9148-8 · DOI · Paper page
  74. Haridas, 2007, Avicins, a novel plant-derived metabolite lowers energy metabolism in tumor cells by targeting the outer mitochondrial membrane, Mitochondrion, 7, 234, 10.1016/j.mito.2006.12.005 · DOI
  75. Wolvetang, 1994, Mitochondrial respiratory chain inhibitors induce apoptosis, FEBS Lett, 339, 40, 10.1016/0014-5793(94)80380-3 · DOI · Paper page
  76. Asoh, 1996, Expression of the apoptosis-mediator Fas is enhanced by dysfunctional mitochondria, J Biochem, 120, 600, 10.1093/oxfordjournals.jbchem.a021455 · doi:10.1093/oxfordjournals.jbchem.a021455
  77. Xiao, 2008, Benzyl Isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells, J Biol Chem, 283, 30151, 10.1074/jbc.M802529200 · DOI · Paper page
  78. Chen, 2007, Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species, J Cell Sci, 120, 4155, 10.1242/jcs.011163 · DOI · Paper page
  79. Prasad, 1982, Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture, Cancer Res, 42, 550
  80. Qian, 1996, RRR-alpha-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells, Nutr Cancer, 25, 9, 10.1080/01635589609514424 · DOI
  81. Neuzil, 2001, Selective cancer cell killing by alpha-tocopheryl succinate, Br J Cancer, 84, 87, 10.1054/bjoc.2000.1559 · DOI · Paper page
  82. Weber, 2002, Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo, Clin Cancer Res, 8, 863
  83. Neuzil, 2007, Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II, J Bioenerg Biomembr, 39, 65, 10.1007/s10863-006-9060-z · DOI
  84. Neuzil, 2006, Molecular mechanism of ‘mitocan’-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins, FEBS Lett, 580, 5125, 10.1016/j.febslet.2006.05.072 · DOI · Paper page
  85. Yu, 2003, RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria, Cancer Res, 63, 2483
  86. Montero, 2008, Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma, Cancer Res, 68, 5246, 10.1158/0008-5472.CAN-07-6161 · DOI · Paper page
  87. Bonnet, 2007, A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth, Cancer Cell, 11, 37, 10.1016/j.ccr.2006.10.020 · DOI · Paper page
  88. Michelakis, 2008, Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer, Br J Cancer, 99, 989, 10.1038/sj.bjc.6604554 · DOI · Paper page
  89. Schulz, 2006, Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited, J Biol Chem, 281, 977, 10.1074/jbc.M511064200 · DOI · Paper page
  90. Polyak, 1997, A model for p53-induced apoptosis, Nature, 389, 300, 10.1038/38525 · DOI · Paper page
  91. Zhou, 2003, Mitochondrial impairment in p53-deficient human cancer cells, Mutagenesis, 18, 287, 10.1093/mutage/18.3.287 · DOI
  92. Nutt, 2005, Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2, Cell, 123, 89, 10.1016/j.cell.2005.07.032 · DOI · Paper page
  93. Marchenko, 2000, Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling, J Biol Chem, 275, 16202, 10.1074/jbc.275.21.16202 · DOI · Paper page
  94. Zache, 2008, PRIMA-1MET inhibits growth of mouse tumors carrying mutant p53, Cell Oncol, 30, 411
  95. Shen, 2008, PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2, Oncogene, 27, 6571, 10.1038/onc.2008.249 · DOI
  96. Wang, 2007, PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax, Biochem Biophys Res Commun, 352, 203, 10.1016/j.bbrc.2006.11.006 · DOI · Paper page

Cited by

See all 162

Metadata

Authors
Gogvadze, V., Orrenius, S., & Zhivotovsky, B.
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2009-02
Volume
19
Issue
1
Pages
57-66
ISSN
1044-579X (ISSN-L)
OpenAlex
W2003959002
Cited by
162
References
15
FWCI
5.21
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.